Dr. David Fajgenbaum

Well,

My pharmaceutical stuff was natural.

We just figured out how to make the exact same thing over and over again.

And so it's a lot grayer than I think that it's easy to wrap our heads around.

And I think that we've just got to follow the data.

And what are the drugs that can help people?

And is there data to suggest that it can help people?

If so, we should put people on them.

And I think try to get less caught up on...

You know, is it from a drug company or, you know, what's the source of it?

But I think just really just just actually track like, you know, is there good data here?

And to your point earlier, like when I was dying from my Castleman disease, there was no data for serolimus to save my life.

I had lab data that made me think it might.

But sometimes you do follow the things that don't have much data because the alternative is that you're going to die and you just you do that.

But if you do have data on drugs, like, you know, what sort of breaks my heart is when I hear about people with terminal cancer that say, I'm not going to take this medicine because it's a pharmaceutical product.

I'm going to take something else.

And then you hear about them passing away.

And you just think to yourself, like, I wish they had given themselves a shot with the traditional pharma stuff.

And who knows if the pharma stuff would have worked.

But we have a lot of data to show that it does work in some people.